Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Economy
Global Metrics

Abeona Therapeutics Current Ratio 2006-2021 | ABEO

For a detailed definition, formula and example for Current Ratio, check out our new background page here.
Abeona Therapeutics current ratio from 2006 to 2021. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
  
Abeona Therapeutics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2021-06-30 $0.08B $0.04B 1.88
2021-03-31 $0.09B $0.04B 2.17
2020-12-31 $0.10B $0.04B 2.33
2020-09-30 $0.11B $0.04B 2.70
2020-06-30 $0.11B $0.04B 2.90
2020-03-31 $0.12B $0.04B 3.24
2019-12-31 $0.13B $0.04B 3.42
2019-09-30 $0.05B $0.02B 2.45
2019-06-30 $0.07B $0.03B 2.54
2019-03-31 $0.07B $0.02B 3.35
2018-12-31 $0.09B $0.02B 4.37
2018-09-30 $0.12B $0.01B 11.09
2018-06-30 $0.12B $0.01B 21.07
2018-03-31 $0.13B $0.01B 20.79
2017-12-31 $0.14B $0.01B 25.07
2017-09-30 $0.06B $0.00B 22.13
2017-06-30 $0.06B $0.00B 14.05
2017-03-31 $0.06B $0.01B 10.52
2016-12-31 $0.07B $0.01B 8.37
2016-09-30 $0.03B $0.01B 4.90
2016-06-30 $0.04B $0.01B 3.98
2016-03-31 $0.04B $0.01B 4.95
2015-12-31 $0.04B $0.00B 27.47
2015-09-30 $0.04B $0.00B 27.83
2015-06-30 $0.03B $0.00B 16.13
2015-03-31 $0.01B $0.00B 6.61
2014-12-31 $0.01B $0.00B 3.99
2014-09-30 $0.00B $0.01B 0.02
2014-06-30 $0.00B $0.01B 0.02
2014-03-31 $0.00B $0.01B 0.04
2013-12-31 $0.00B $0.01B 0.06
2013-09-30 $0.00B $0.01B 0.13
2013-06-30 $0.00B $0.01B 0.30
2013-03-31 $0.00B $0.01B 0.22
2012-12-31 $0.00B $0.01B 0.25
2012-09-30 $0.00B $0.01B 0.10
2012-06-30 $0.00B $0.01B 0.15
2012-03-31 $0.00B $0.01B 0.22
2011-12-31 $0.00B $0.01B 0.27
2011-09-30 $0.00B $0.01B 0.12
2011-06-30 $0.00B $0.01B 0.35
2011-03-31 $0.01B $0.02B 0.42
2010-12-31 $0.01B $0.01B 0.57
2010-09-30 $0.00B $0.01B 0.11
2010-06-30 $0.00B $0.01B 0.35
2010-03-31 $0.00B $0.01B 0.51
2009-12-31 $0.00B $0.01B 0.08
2009-09-30 $0.00B $0.01B 0.22
2009-06-30 $0.00B $0.01B 0.18
2009-03-31 $0.00B $0.01B 0.38
2008-12-31 $0.00B $0.01B 0.39
2008-09-30 $0.01B $0.01B 1.02
2008-06-30 $0.01B $0.00B 1.72
2008-03-31 $0.01B $0.00B 2.73
2007-12-31 $0.01B $0.00B 4.03
2007-09-30 $0.00B $0.02B 0.17
2007-06-30 $0.00B $0.01B 0.19
2007-03-31 $0.00B $0.01B 0.29
2006-12-31 $0.01B $0.01B 0.47
2006-09-30 $0.01B $0.02B 0.35
2006-06-30 $0.01B $0.02B 0.42
2006-03-31 $0.01B $0.01B 0.72
2005-12-31 $0.01B $0.00B 1.35
2005-09-30 $0.00B $0.01B 0.02
2005-06-30 $0.00B $0.02B 0.19
2005-03-31 $0.01B $0.02B 0.35
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.089B $0.010B
Abeona Therapeutics, Inc. is engaged in developing and delivering gene therapy and plasma-based products for rare diseases. Abeona Therapeutics Inc., formerly known as PlasmaTech Biopharmaceuticals, Inc., is based in Dallas, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.416B 8.62
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.526B 21.21
Biohaven Pharmaceutical Holding (BHVN) United States $9.249B 0.00
Emergent Biosolutions (EBS) United States $2.705B 6.53
Arcus Biosciences (RCUS) United States $2.404B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.873B 0.00
Myovant Sciences (MYOV) United Kingdom $1.831B 0.00
Zymeworks (ZYME) Canada $1.080B 0.00
Ambrx Biopharma (AMAM) United States $0.464B 0.00
SQZ Biotechnologies (SQZ) United States $0.372B 0.00
Enzo Biochem (ENZ) United States $0.161B 15.86